参考文献 References
[1] 戴卫波, 梅全喜, 孔祥廉. 积雪草的化学成分与药理作用研究进展[J]. 时珍国医国药, 2009, 20(6): 1566-1568.
[2] Li Z, You K, Li J, et al. Madecassoside suppresses proliferation and invasiveness of HGF-induced human hepatocellular carcinoma cells via PKC-cMET-ERK1/2-COX-2-PGE2 pathway[J]. Int Immunopharmacol. 2016; 33: 24-32.
[3] 江彬, 周倩, 卢柳媚, 等. 羟基积雪草苷对人宫颈癌细胞C-33A/CaSki细胞凋亡的影响[J]. 中医临床研究, 2019, 11(21): 78-80.
[4] Jung E, Lee JA, Shin S, et al. Madecassoside inhibits melanin synthesis by blocking ultraviolet-induced inflammation[J]. Molecules. 2013; 18(12): 15724-36.
[5] Song J, Xu H, Lu Q, et al. Madecassoside suppresses migration of fibroblasts from keloids: involvement of p38 kinase and PI3K signaling pathways[J]. Burns. 2012; 38(5): 677-84.
[6] Hou Q, Li M, Lu YH, et al. Burn wound healing properties of asiaticoside and madecassoside[J]. Exp Ther Med. 2016; 12(3): 1269-1274.
[7] 白纪红, 赵日红, 吕秋军, 等. 羟基积雪草苷的抗高血压作用及其特点研究[J]. 中药药理与临床, 2010; 26(1): 18-21.
[8] Cao W, Li XQ, Zhang XN, et al. Madecassoside suppresses LPS-induced TNF-alpha production in cardiomyocytes through inhibition of ERK, p38, and NF-kappaB activity[J]. Int Immunopharmacol. 2010. 10(7): 723-9.
[9] 李桂桂, 卞广兴, 任建平, 等. 羟基积雪草苷对兔心肌缺血再灌注损伤的保护作用[J]. 药学学报, 2007, (05): 475-480.
[10] 张思思, 蔡江晖, 万敬员, 等. 羟基积雪草苷对LPS诱导小胶质细胞增殖的抑制作用及机制研究[J]. 中国病理生理杂志, 2015; 31(3): 428-434.
[11] Du B, Zhang Z, Li N. Madecassoside prevents Abeta(25-35)-induced inflammatory responses and autophagy in neuronal cells through the class III PI3K/Beclin-1/Bcl-2 pathway[J]. Int Immunopharmacol. 2014; 20(1): 221-8.
[12] 贾颜锋, 陈伟. 羟基积雪草苷对大鼠创伤性颅脑损伤后神经功能障碍的改善作用及机制研究[J]. 创伤外科杂志. 2021; 23(07): 546-550.
[13] 王亭, 魏志凤, 窦艳侬, 等. 羟基积雪草苷对胶原关节炎大鼠肠道黏膜免疫的影响[J]. 中药材. 2015; 38(2): 333-338.
[14] Yu WG, Shen Y, Wu JZ, et al. Madecassoside impedes invasion of rheumatoid fibroblast-like synoviocyte from adjuvant arthritis rats via inhibition of NF-κB-mediated matrix metalloproteinase-13 expression[J]. Chinese Journal of Natural Medicines. 2018; 16(5): 330-338.
[15] 张利, 孙胜禄, 范海波, 等. 羟基积雪草苷对佐剂关节炎大鼠滑膜成纤维细胞活化的影响[J]. 中国实验方剂学杂志. 2014; 20(8): 173-177.
[16] Wang W, Wu L, Li Q, et al. Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-kappaB and activating Nrf2/HO-1 signaling[J]. Biomed Pharmacother. 2018; 103: 1137-1145.
[17] Su Z, Ye J, Qin Z, et al. Protective effects of madecasso-side against Doxorubicin induced nephrotoxicity in vivo and in vitro[J]. Sci Rep. 2015; 5: 18314.
[18] Lu GX, Bian DF, Ji Y, et al. Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice by down-regulating collagen deposition[J]. Phytother Res. 2014; 28(8): 1224-31.
[19] 赵刚, 刘颖菊, 白洁如, 等. 羟基积雪草苷对急性脊髓损伤大鼠的保护作用[J]. 时珍国医国药. 2011; 22(9): 2129-2131.